Alibaba & AUS Agree to $600 Million DOJ Resolution Over Illegal Pharmaceutical Sales
Alibaba had policies forbidding merchants from selling illegal pharmaceuticals, listed chemicals and pharmaceutical counterfeiting equipment through its marketplaces. Employees questioned whether those policies were working. Merchants found ways around them. Some shifted conversations into Alibaba's private messaging system before directing buyers to encrypted third-party platforms. Others continued operating even after concerns had been identified. According to the U.S. Department of Justice, the controls never kept pace with the activity they were supposed to stop. That failure has now produced one of the largest corporate resolutions involving online marketplace compliance.
